SCHEMBL2867196

SCHEMBL2867196

CC(=O)c1ccc(-c2n[nH]c3ccc(NC(=O)CCOc4ccccc4)cc23)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.64
SMN1; SMN2 Q16637 2/20 0.64
RAB9A P51151 3/20 0.59
MAPK1 P28482 1/20 0.54
KDM4E B2RXH2 1/20 0.52
ALDH1A1 P00352 2/20 0.51
TTK P33981 2/20 0.51
MAPK8 P45983 1/20 0.51
KMT2A Q03164 4/20 0.49
AURKA O14965 3/20 0.49
AURKB Q96GD4 3/20 0.49
NPC1 O15118 2/20 0.49
TP53 P04637 1/20 0.49
LRRK2 Q5S007 1/20 0.49
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
MEN1 O00255 2/20 0.48
CYP2D6 P10635 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2861158 0.80 TTK (0.65) MAPTSMN1; SMN2RAB9ATTKMAPK8
SCHEMBL2864712 0.75 ITK (0.56) KDM4EALDH1A1TTKKMT2AAURKA
SCHEMBL2870192 0.74 TTK (0.50) TTKMAPK8AURKAAURKBLRRK2
SCHEMBL2866772 0.74 EPHX2 (0.52) MAPTSMN1; SMN2RAB9AMAPK1KDM4E
SCHEMBL8260089 0.74 TTK (0.69) KDM4ETTKMAPK8KMT2AAURKA
SCHEMBL1460668 0.71 MAP2K4 (0.49) MAPTMAPK1TTKAURKAAURKB
SCHEMBL5377699 0.71 AURKA (0.60) MAPK1AURKALRRK2ITK
SCHEMBL8251866 0.71 JAK2 (0.74) RAB9AAURKANPC1LRRK2ITK
SCHEMBL2567175 0.71 NTRK1 (0.53) MAPK1TTKMAPK8AURKAAURKB
SCHEMBL14514347 0.71 ITK (0.67) MAPK1AURKALRRK2ITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAPT 2644/4885SMN1; SMN2 4812/4885RAB9A 2355/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 MAPT 2892/4885SMN1; SMN2 4781/4885RAB9A 2697/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 MAPT 2644/4885SMN1; SMN2 4812/4885RAB9A 2355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.